default search action

combined dblp search
author search
venue search
publication search

ask others

Katy Billot

> Home > Persons

Person information

Refine list

refinements active!

zoomed in on ?? of ?? records

view refined list in

export refined list as

showing all ?? records

2020 – today

see FAQ

What is the meaning of the colors in the publication lists?

2024
[j2]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - journals/midm/FaviezCGZBPFDRCALSB24
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/midm/FaviezCGZBPFDRCALSB24
Carole Faviez, Xiaoyi Chen, Nicolas Garcelon, Mohamad Zaidan, Katy Billot, Friederike Petzold, Hassan Faour, Maxime Douillet, Jean-Michel Rozet, Valerie Cormier-Daire, Tania Attié-Bitach, Stanislas Lyonnet, Sophie Saunier, Anita Burgun:
Objectivizing issues in the diagnosis of complex rare diseases: lessons learned from testing existing diagnosis support systems on ciliopathies. BMC Medical Informatics Decis. Mak. 24(1): 134 (2024)

2010 – 2019

see FAQ

What is the meaning of the colors in the publication lists?

2019
[j1]
- view
  - electronic edition via DOI (open access)
  - details & citations
  authority control:
- export record
  dblp key:
  - journals/jbi/ChenGNBLBGMBVFD19
- ask others
- share record
  persistent URL:
  - https://dblp.org/rec/journals/jbi/ChenGNBLBGMBVFD19
Xiaoyi Chen, Nicolas Garcelon, Antoine Neuraz, Katy Billot, Marc Lelarge, Thomas Bonald, Hugo Garcia, Yoann Martin, Vincent Benoit, Marc Vincent, Hassan Faour, Maxime Douillet, Stanislas Lyonnet, Sophie Saunier, Anita Burgun:
Phenotypic similarity for rare disease: Ciliopathy diagnoses and subtyping. J. Biomed. Informatics 100 (2019)

manage site settings

To protect your privacy, all features that rely on external API calls from your browser are turned off by default. You need to opt-in for them to become active. All settings here will be stored as cookies with your web browser. For more information see our F.A.Q.